Legal foundations of certification courses


Official MIBB-Certification courses, acknowledged by the MIBB working group and held under the patronate of the „Swiss Society of Senology“ must meet the following conditions:

  1. Target audience: Certification course for new MIBB operators, accessible for gynecologists, radiologists and surgeons (incl soon to be board certified physicians in these fields)
  2. Goal: transmission of the legal foundations for the execution of vacuum-assisted biopsies (VABs) in Switzerland, tasks inside of the MIBB working group, insertion of data into
    Transmission of the theoretical basics about execution of the VABs (mammo-guided, ultrasound-guided, MR-guided).
    Practical training as second obligatory part
    Minimum 6 hours course duration
  3. At least one course per year to be offered in Switzerland, preferably in different geographic and linguistic regions. So far offered: MIBB Certification course in varying locations in the fall time; SGG-certification course for gynecologists in St Moritz in spring time (as of 2022)
  4. The courses will be announced on the websites of, on and
  5. Minimal basic conditions to achieve the certification: registration for the course with downpayment, prove of 5 executed VABs under supervision for new members and membership at the SGS (Swiss Society of Senology).
    Further details on this website under membership/accreditation
  6. The course participant receives a certificate
  7. For support of the event sponsoring is customary; acknowledgement of all industrial companies, no mono sponsoring
Operators from abroad:
  1. Written prove of the executed VABs in the last 2 years (e.g. recognition by the former employer): at least 12 VABs/year
  2. The operators must be informed in detail about the legal aspects of the MIBB Certification, as well as the background and utility of data insertion in Therefore the operator receives the publication of the consensus statement of Köchli et al, 2008 for lecture. This has to be confirmed as a written consent.


Minimum technical and procedural requirements to achieve high accuracy and reduce undersampling.

  1. In general, needle sizes between <7G and >11G can be considered for MIBB procedures.
  2. Number and volume of samples depend on needle size. As there is evidence in the literature that the risk of upstaging correlates inversely with tissue volume, the smaller the needle, the more samples are required. As a recommendation, at least 6 samples should be taken with 7G needles and at least 12 samples with 11G needles.
  3. Stopping stereotactic VAB as soon as calcifications are found may lead to false negative results. Malignancy can be found in surrounding non-calcified tissue, so it is recommended to take as much tissue as possible or clinically appropriate to avoid under sampling.


Useful links:

Breast Cancer Conferences
  • European Breast Cancer Conference (EBCC):
  • Global Breast Cancer Conference (GBCC):
  • St. Gallen International Breast Cancer Conference (BCC):
  • San Antonio Breast Cancer Symposium (SABCS):
  • World Congress on Controversies in Breast Cancer (CoBrCa):
Breast Cancer Information
  • American Cancer Society (ACS):
  • National Cancer Institut (NIH):
  • World Health Organization (WHO): Breast
  • Cancer MATTERS:
  • European Society of Medical Oncology (ESMO):
  • Breast Cancer Now: Susan G. Komen:
  • Pink Ribbon: A Sister’s Hope:
  • ESR Education on Demand:
Scientific Societies
  • European Cancer Organisation:
  • European Society of Radiology (ESR):
  • European School of Radiology (ESOR):
  • Society of Breast Imaging (SBI):